Summary

Market Overview

According to DIResearch＇s in-depth investigation and research, the global Oral Proteins and Peptides market size will reach 4,539.32 Million USD in 2026 and is projected to reach 11,654.79 Million USD by 2033, with a CAGR of 14.42% (2026-2033). Notably, the China Oral Proteins and Peptides market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Oral proteins and peptides are biologically active molecules that are administered through oral ingestion, allowing them to be absorbed and exert their therapeutic effects within the human body. These substances can include proteins, peptides, and antibodies designed to treat various medical conditions. Developing effective oral protein and peptide formulations is a significant challenge due to the digestive processes in the gastrointestinal tract. However, research and innovations in drug delivery technologies, such as nanoparticles, oral capsules, and mucoadhesive formulations, have expanded the possibilities of oral administration for these therapeutic molecules. This approach offers the advantage of non-invasive drug delivery and enhanced patient compliance, particularly for long-term treatments, as it eliminates the need for injections or intravenous infusions. It has the potential to revolutionize the treatment of conditions ranging from diabetes to autoimmune diseases, offering more convenient and patient-friendly options for managing various medical disorders.

The major global  manufacturers of Oral Proteins and Peptides include Ironwood & Allergan, Novo Nordisk, Synergy Pharma, Novartis, Amryt Pharma, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Oral Proteins and Peptides. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Oral Proteins and Peptides market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Oral Proteins and Peptides market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oral Proteins and Peptides industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Oral Proteins and Peptides Include:

Ironwood & Allergan

Novo Nordisk

Synergy Pharma

Novartis

Amryt Pharma

Oral Proteins and Peptides Product Segment Include:

Linaclotide

Insulin

Plecanatide

Cyclosporine

Octreotide

Oral Proteins and Peptides Product Application Include:

Gastric & Digestive Disorders

Bone Diseases

Diabetes

Hormonal Disorders




Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Oral Proteins and Peptides Industry PESTEL Analysis

Chapter 3: Global Oral Proteins and Peptides Industry Porter’s Five Forces Analysis

Chapter 4: Global Oral Proteins and Peptides Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Oral Proteins and Peptides Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Oral Proteins and Peptides Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

ページTOPに戻る

Table of Contents

Table of Contents

1 Oral Proteins and Peptides Market Overview

  1.1 Product Definition and Statistical Scope

   1.2 Oral Proteins and Peptides Product by Type

       1.2.1 Linaclotide

       1.2.2 Insulin

       1.2.3 Plecanatide

       1.2.4 Cyclosporine

       1.2.5 Octreotide

   1.3 Oral Proteins and Peptides Product by Application

       1.3.1 Gastric & Digestive Disorders

       1.3.2 Bone Diseases

       1.3.3 Diabetes

       1.3.4 Hormonal Disorders

  1.4 Global Oral Proteins and Peptides Market Revenue and Sales Analysis

       1.4.1 Global Oral Proteins and Peptides Revenue Market Size Analysis (2021-2033)

       1.4.2 Global Oral Proteins and Peptides Sales Market Size Analysis (2021-2033)

       1.4.3 Global Oral Proteins and Peptides Market Sales Price Trend Analysis (2021-2033)

  1.5 Oral Proteins and Peptides Industry Trends and Innovation

       1.5.1 Oral Proteins and Peptides Industry Trends and Innovation

       1.5.2 Oral Proteins and Peptides Market Drivers and Challenges

2 Oral Proteins and Peptides Market PESTEL Analysis

   2.1 Political Factors Analysis

   2.2 Economic Factors Analysis

   2.3 Social Factors Analysis

   2.4 Technological Factors Analysis

   2.5 Environmental Factors Analysis

   2.6 Legal Factors Analysis

3 Oral Proteins and Peptides Market Porter's Five Forces Analysis

   3.1 Competitive Rivalry

   3.2 Threat of New Entrants

   3.3 Bargaining Power of Suppliers

   3.4 Bargaining Power of Buyers

   3.5 Threat of Substitutes

4 Global Oral Proteins and Peptides Market Analysis by Regions

   4.1 Oral Proteins and Peptides Overall Market: 2025 VS 2026 VS 2033

   4.2 Global Oral Proteins and Peptides Revenue and Forecast Analysis (2021-2033)

       4.2.1 Global Oral Proteins and Peptides Revenue and Market Share by Region (2021-2026)

       4.2.2 Global Oral Proteins and Peptides Revenue and Market Share Forecast by Region (2027-2033)

   4.3 Global Oral Proteins and Peptides Sales and Forecast Analysis (2021-2033)

       4.3.1 Global Oral Proteins and Peptides Sales and Market Share by Region (2021-2026)

       4.3.2 Global Oral Proteins and Peptides Sales and Market Share Forecast by Region (2027-2033)

   4.4 Global Oral Proteins and Peptides Sales Price Trend Analysis (2021-2033)

5 Global Oral Proteins and Peptides Market Size by Type and Application

   5.1 Global Oral Proteins and Peptides Market Size by Type

       5.1.1 Global Oral Proteins and Peptides Revenue and Forecast Analysis by Type (2021-2033)

       5.1.2 Global Oral Proteins and Peptides Sales and Forecast Analysis by Type (2021-2033)

   5.2 Global Oral Proteins and Peptides Market Size by Application

       5.2.1 Global Oral Proteins and Peptides Revenue and Forecast Analysis by Application (2021-2033)

       5.2.2 Global Oral Proteins and Peptides Sales and Forecast Analysis by Application (2021-2033)

6 North America

   6.1 North America Oral Proteins and Peptides Market Size and Growth Rate Analysis (2021-2033)

   6.2 North America Key Manufacturers Analysis

   6.3 North America Oral Proteins and Peptides Market Size by Type

       6.3.1 North America Oral Proteins and Peptides Sales by Type (2021-2033)

       6.3.2 North America Oral Proteins and Peptides Revenue by Type (2021-2033)

   6.4 North America Oral Proteins and Peptides Market Size by Application

       6.4.1 North America Oral Proteins and Peptides Sales by Application (2021-2033)

       6.4.2 North America Oral Proteins and Peptides Revenue by Application (2021-2033)

   6.5 North America Oral Proteins and Peptides Market Size by Country

       6.5.1 US

       6.5.2 Canada

7 Europe

   7.1 Europe Oral Proteins and Peptides Market Size and Growth Rate Analysis (2021-2033)

   7.2 Europe Key Manufacturers Analysis

   7.3 Europe Oral Proteins and Peptides Market Size by Type

       7.3.1 Europe Oral Proteins and Peptides Sales by Type (2021-2033)

       7.3.2 Europe Oral Proteins and Peptides Revenue by Type (2021-2033)

   7.4 Europe Oral Proteins and Peptides Market Size by Application

       7.4.1 Europe Oral Proteins and Peptides Sales by Application (2021-2033)

       7.4.2 Europe Oral Proteins and Peptides Revenue by Application (2021-2033)

   7.5 Europe Oral Proteins and Peptides Market Size by Country

       7.5.1 Germany

       7.5.2 France

       7.5.3 United Kingdom

       7.5.4 Italy

       7.5.5 Spain

       7.5.6 Benelux

8 China

   8.1 China Oral Proteins and Peptides Market Size and Growth Rate Analysis (2021-2033)

   8.2 China Key Manufacturers Analysis

   8.3 China Oral Proteins and Peptides Market Size by Type

       8.3.1 China Oral Proteins and Peptides Sales by Type (2021-2033)

       8.3.2 China Oral Proteins and Peptides Revenue by Type (2021-2033)

   8.4 China Oral Proteins and Peptides Market Size by Application

       8.4.1 China Oral Proteins and Peptides Sales by Application (2021-2033)

       8.4.2 China Oral Proteins and Peptides Revenue by Application (2021-2033)

9 APAC (excl. China)

   9.1 APAC (excl. China) Oral Proteins and Peptides Market Size and Growth Rate Analysis (2021-2033)

   9.2 APAC (excl. China) Key Manufacturers Analysis

   9.3 APAC (excl. China) Oral Proteins and Peptides Market Size by Type

       9.3.1 APAC (excl. China) Oral Proteins and Peptides Sales by Type (2021-2033)

       9.3.2 APAC (excl. China) Oral Proteins and Peptides Revenue by Type (2021-2033)

   9.4 APAC (excl. China) Oral Proteins and Peptides Market Size by Application

       9.4.1 APAC (excl. China) Oral Proteins and Peptides Sales by Application (2021-2033)

       9.4.2 APAC (excl. China) Oral Proteins and Peptides Revenue by Application (2021-2033)

   9.5 APAC (excl. China) Oral Proteins and Peptides Market Size by Country

       9.5.1 Japan

       9.5.2 South Korea

       9.5.3 India

       9.5.4 Australia

       9.5.5 Southeast Asia

10 Latin America

   10.1 Latin America Oral Proteins and Peptides Market Size and Growth Rate Analysis (2021-2033)

   10.2 Latin America Key Manufacturers Analysis

   10.3 Latin America Oral Proteins and Peptides Market Size by Type

       10.3.1 Latin America Oral Proteins and Peptides Sales by Type (2021-2033)

       10.3.2 Latin America Oral Proteins and Peptides Revenue by Type (2021-2033)

   10.4 Latin America Oral Proteins and Peptides Market Size by Application

       10.4.1 Latin America Oral Proteins and Peptides Sales by Application (2021-2033)

       10.4.2 Latin America Oral Proteins and Peptides Revenue by Application (2021-2033)

   10.5 Latin America Oral Proteins and Peptides Market Size by Country

   10.6 Latin America Oral Proteins and Peptides Market Size by Country

       10.6.1 Mexico

       10.6.2 Brazil

11 Middle East & Africa

   11.1 Middle East & Africa Oral Proteins and Peptides Market Size and Growth Rate Analysis (2021-2033)

   11.2 Middle East & Africa Key Manufacturers Analysis

   11.3 Middle East & Africa Oral Proteins and Peptides Market Size by Type

       11.3.1 Middle East & Africa Oral Proteins and Peptides Sales by Type (2021-2033)

       11.3.2 Middle East & Africa Oral Proteins and Peptides Revenue by Type (2021-2033)

   11.4 Middle East & Africa Oral Proteins and Peptides Market Size by Application

       11.4.1 Middle East & Africa Oral Proteins and Peptides Sales by Application (2021-2033)

       11.4.2 Middle East & Africa Oral Proteins and Peptides Revenue by Application (2021-2033)

   11.5 Middle East Oral Proteins and Peptides Market Size by Country

       11.5.1 Saudi Arabia

       11.5.2 South Africa

12 Competition by Manufacturers

   12.1 Global Oral Proteins and Peptides Market Sales, Revenue and Price by Key Manufacturers (2021-2026)

       12.1.1 Global Oral Proteins and Peptides Market Sales by Key Manufacturers (2021-2026)

       12.1.2 Global Oral Proteins and Peptides Market Revenue by Key Manufacturers (2021-2026)

       12.1.3 Global Oral Proteins and Peptides Average Sales Price by Manufacturers (2021-2026)

   12.2 Oral Proteins and Peptides Competitive Landscape Analysis and Market Dynamic

       12.2.1 Oral Proteins and Peptides Competitive Landscape Analysis

       12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

       12.2.3 Market Dynamic

13 Key Companies Analysis

   13.1 Ironwood & Allergan

       13.1.1 Ironwood & Allergan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.1.2 Ironwood & Allergan Oral Proteins and Peptides Product Portfolio

       13.1.3 Ironwood & Allergan Oral Proteins and Peptides Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026)

   13.2 Novo Nordisk

       13.2.1 Novo Nordisk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.2.2 Novo Nordisk Oral Proteins and Peptides Product Portfolio

       13.2.3 Novo Nordisk Oral Proteins and Peptides Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026)

   13.3 Synergy Pharma

       13.3.1 Synergy Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.3.2 Synergy Pharma Oral Proteins and Peptides Product Portfolio

       13.3.3 Synergy Pharma Oral Proteins and Peptides Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026)

   13.4 Novartis

       13.4.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.4.2 Novartis Oral Proteins and Peptides Product Portfolio

       13.4.3 Novartis Oral Proteins and Peptides Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026)

   13.5 Amryt Pharma

       13.5.1 Amryt Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.5.2 Amryt Pharma Oral Proteins and Peptides Product Portfolio

       13.5.3 Amryt Pharma Oral Proteins and Peptides Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2026)

14 Industry Chain Analysis

   14.1 Oral Proteins and Peptides Industry Chain Analysis

   14.2 Oral Proteins and Peptides Industry Raw Material and Suppliers Analysis

       14.2.1 Oral Proteins and Peptides Key Raw Material Supply Analysis

       14.2.2 Raw Material Suppliers and Contact Information

   14.3 Oral Proteins and Peptides Typical Downstream Customers

   14.4 Oral Proteins and Peptides Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

   16.1 Methodology/Research Approach

   16.2 Research Scope

   16.3 Benchmarks and Assumptions

   16.4 Date Source

       16.4.1 Primary Sources

       16.4.2 Secondary Sources

   16.5 Data Cross Validation

   16.6 Disclaimer